Maximizing AI reliability through anticipatory thinking and model risk audits
AI Magazine · 2023-06 · 44 (2) · 173-184
DOI: 10.1002/aaai.12099 ↗Kurz gefasst
Fachartikel in der Zeitschrift AI Magazine, online erschienen am 23.06.2023. Verfasst von Phil Munz und 2 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
AI is transforming the way we live and work, with the potential to improve our lives in many ways. However, there are risks associated with AI deployments including failures of model robustness and security, explainability and interpretability, bias and fairness, and privacy and ethics. While there are international efforts to define governance standards for responsible AI, these are currently only principles‐based, leaving organizations uncertain as to how they can prepare for emerging regulations or evaluate their effectiveness. We propose the use of anticipatory thinking and a flexible model risk audit (MRA) framework to bridge this gap and enable organizations to take an advantage of the benefits of responsible AI. This approach enables organizations to characterize risk at the model level and to apply the anticipatory thinking employed by high reliability organizations to achieve responsible AI deployments.
Zitieren
APA
Munz, P., Hennick, M., & Stewart, J. (2023). Maximizing AI reliability through anticipatory thinking and model risk audits. AI Magazine, 44(2), 173-184. https://doi.org/10.1002/aaai.12099
Vancouver
Munz P, Hennick M, Stewart J. Maximizing AI reliability through anticipatory thinking and model risk audits. AI Magazine. 2023;44(2):173-184. doi:10.1002/aaai.12099
BibTeX
@article{Munz2023,
author = {Munz, Phil and Hennick, Max and Stewart, James},
title = {Maximizing AI reliability through anticipatory thinking and model risk audits},
journal = {AI Magazine},
year = {2023},
volume = {44},
number = {2},
pages = {173--184},
doi = {10.1002/aaai.12099}
}
EUVIMED